Blogs
News
-
Collaborations | 04 Feb, 2026
Porton Advanced’s Comprehensive CDMO Service Facilitates IND Approval for CSPC’s Pioneering in vivo CAR‑T Therapy in China
-
Collaborations | 19 Dec, 2025
Porton Advanced’s End-to-End Cell Therapy CDMO Service Accelerates NMPA Approval of Gene MiNK Biotechnology’s Innovative NK Therapy












